Mahvash disease: a novel case of apparent monoallelic disease and a novel cause of hypoglycaemia
Endocrine Oncology · 2026-01-01 · 6 (1)
DOI: 10.1530/eo-26-0063 ↗Abstract
Abstract Glucagon cell hyperplasia and neoplasia (GCHN), also known as Mahvash disease (MVAH), is a rare pancreatic neuroendocrine disorder. In most cases, the disorder is autosomal recessive and caused by inactivating mutations in the glucagon receptor (GCGR), leading to pancreatic α-cell hyperplasia and hyperglucagonaemia, with sporadic association with hypoglycaemia. We present an adult female patient presenting with recurrent hypoglycaemia: she had an enlarged pancreas and very high levels of glucagon. Severe hypoglycaemia is not generally seen in most cases of Mahvash syndrome. Genetic testing showed an essential splice variant in GCGR that predicts loss of protein production. It is most likely a single pathogenic variant in the GCGR gene, although the literature reports only a recessive phenotype. We cannot entirely exclude an autosomal recessive condition in terms of mutations in promoter or relevant intronic regions.
EUVIMED